Maya Bloomberg shares how AI may impact sickle cell tests in the screening, diagnosis, and treatment of patients.

Awareness must be increased about preeclampsia, a critical medical issue during and sometimes after pregnancy. Here’s a look at preeclampsia and potential risks to BIPOC and underserved patient pregnancy.

Sickle cell disease is listed in some research as a cause of focal segmental glomerulosclerosis (FSGS), and APOL1 kidney disease treatments are under research. Here’s a look at FSGS and the APOL1 gene and how they relate to SCD and other conditions.

Sickle cell disease (SCD) care is not always easy to locate, and we at DHH want to continue our efforts working toward health equity for SCD patients. Here’s a look at sickle cell disease resources outside the U.S. along with a research update.

Sexual and reproductive health (SRH) concerns can be top of mind for some female AYA sickle cell disease patients. What do these concerns of these patients show? Here’s a look at the results of a recent sickle cell disease survey.

Dr. Marwan Shaikh and hematology nurse practitioner Maya Bloomberg provide an update on current treatments, research study results, and treatment improvements currently in development.

Sickle cell disease advocate and care partner Carla Lewis shares things that have triggered pain crisis for her son and actions she took to help him avoid pain crisis over the years.

Sickle cell disease care partner Carla Lewis shares details about her son’s journey including what they encountered with support, helpful treatments, and how treatments have evolved over the years – while Maya Bloomberg shares advice for families with sickle cell trait.

Dr. Marwan Shaikh, hematology nurse practitioner Maya Bloomberg, and Carla Lewis explain ways that sickle cell patients and care partners can help reduce the cost of sickle cell disease treatments.

Sickle cell disease patient advocate Carla Lewis, hematology nurse practitioner Maya Bloomberg, and Dr. Marwan Shaikh explain resources patients and care partners can utilize to take advantage of financial assistance programs and Medicaid and how to optimize financial assistance resources.

Dr. Marwan Shaikh and Maya Bloomberg explain obstacles for patients in sickle cell disease care, challenges to researchers in finding and refining cures, and how patients and others can help improve the possibilities of cures.

As part of ongoing efforts to expand sickle cell disease knowledge and to reduce health inequities, DHH hosted its first Sickle Cell Health Hub Huddle with sickle cell disease experts.

Dr. Marwan Shaikh, Maya Bloomberg, and Carla Lewis, share challenges that young adult SCD patients may encounter with their care and offer advice for how patients can advocate for their best care.

Maya Bloomberg explains problems that can develop during pain episodes that sickle cell disease patients and their care providers should be aware of.

Dr. Seethal Jacob explains results of a pre-clinical study on the use of plant extracts versus hydroxyurea in sickling of the blood and how studies could move forward for additional treatment options.

Dr. Seethal Jacob shares scientific data about those being hospitalized for COVID-19 infection and what sickle cell patients and loved ones can do to protect against COVID complications.

Dr. Seethal Jacob explains the potential impact of and clinical trials in process on gene editing therapies for sickle cell care.

Dr. Seethal Jacob explains how blood donations and transfusions help with reducing risk of sickle cell disease complications and which population groups are especially needed to donate blood.

Dr. Seethal Jacob explains how the two conditions differ, when symptoms can manifest, and subtypes of the blood disorder.

Dr. Seethal Jacob shares common health disparities and care disparities seen for sickle cell patients and changes that can improve their care and health outcomes.